
pmid: 10691319
We report a 50-year-old woman, with overt hypothyroidism undergoing thyrotropin (TSH)-stimulating hormone suppressive levothyroxine (LT4) treatment after subtotal thyroidectomy. At her first visit to our department, the laboratory results revealed a borderline low free thyroxine (FT4) level accompanied by a clearly elevated TSH level. Both parameters did not significantly change during therapy with an oral dose of 500 microg of LT4. Investigations revealed malabsorption of oral administrated LT4. Thyroid serum hormone levels only became normal during parenteral therapy with LT4.
Thyroid Gland, Administration, Oral, Thyrotropin, Middle Aged, Carcinoma, Papillary, Thyroxine, Hypothyroidism, Malabsorption Syndromes, Thyroidectomy, Humans, Triiodothyronine, Female, Infusions, Parenteral, Thyroid Neoplasms
Thyroid Gland, Administration, Oral, Thyrotropin, Middle Aged, Carcinoma, Papillary, Thyroxine, Hypothyroidism, Malabsorption Syndromes, Thyroidectomy, Humans, Triiodothyronine, Female, Infusions, Parenteral, Thyroid Neoplasms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 30 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
